The expression of CD64 was observed to be heterogeneous in ccRCC tumor tissues; CD64 staining was assessed by measuring the CD64+ area in ccRCC tumor tissues (Figure 4c). The gene discussed is FCGR1A; the disease is nonpapillary renal cell carcinoma.